These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9120665)
21. What, if anything, is controversial about calcium antagonists? Messerli FH Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430 [TBL] [Abstract][Full Text] [Related]
22. The clinical performance of nicardipine in elderly hypertensive patients with concomitant diseases. Leonetti G Am Heart J; 1989 Jan; 117(1):266-9. PubMed ID: 2911986 [TBL] [Abstract][Full Text] [Related]
24. Both a calcium antagonist and ACE inhibitor reverse hypertrophy in hypertension but a calcium antagonist also depresses contractility. Sumimoto T; Ochi T; Ito T; Joh T; Muneta S; Hiwada K Cardiovasc Drugs Ther; 1997 Mar; 11(1):27-32. PubMed ID: 9140674 [TBL] [Abstract][Full Text] [Related]
25. Tolerability and safety of a calcium channel blocker in comparison with a diuretic in the treatment of elderly patients with hypertension: secondary analysis of the NICS-EH. Kuwajima I; Kuramoto K; Ogihara T; Iimura O; Abe K; Saruta T; Ishii M; Hiwada K; Fujishima M; Fukiyama K; Hypertens Res; 2001 Sep; 24(5):475-80. PubMed ID: 11675939 [TBL] [Abstract][Full Text] [Related]
26. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
27. Are calcium antagonists the best option in elderly hypertensives? Forette F; Bert P; Rigaud AS J Hypertens Suppl; 1994 Sep; 12(6):S19-23. PubMed ID: 7799105 [TBL] [Abstract][Full Text] [Related]
31. Correlation between predicted theoretical mechanistic biochemistry (TMB) data and therapeutic effects in the management of vascular disorders with calcium channel blockers. Akintonwa DA; Odigwe CO Med Hypotheses; 2000 Jun; 54(6):944-7. PubMed ID: 10867744 [TBL] [Abstract][Full Text] [Related]
32. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Khan NA; McAlister FA; Rabkin SW; Padwal R; Feldman RD; Campbell NR; Leiter LA; Lewanczuk RZ; Schiffrin EL; Hill MD; Arnold M; Moe G; Campbell TS; Herbert C; Milot A; Stone JA; Burgess E; Hemmelgarn B; Jones C; Larochelle P; Ogilvie RI; Houlden R; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Dechamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Tobe S; Touyz RM; Can J Cardiol; 2006 May; 22(7):583-93. PubMed ID: 16755313 [TBL] [Abstract][Full Text] [Related]
33. The case for beta-blockers as first-line antihypertensive therapy. Cruickshank JM J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111 [TBL] [Abstract][Full Text] [Related]
34. Nicardipine retard in the therapy of elderly diabetic hypertensives: final report of observational study. Antonicelli R; Pagelli P; Paciaroni E J Hypertens Suppl; 1992 Apr; 10(2):S69-72. PubMed ID: 1593306 [TBL] [Abstract][Full Text] [Related]
35. Hypertension in elderly--an overview. Bhattacharyya A; Das P J Indian Med Assoc; 1999 Mar; 97(3):96-101. PubMed ID: 10652909 [TBL] [Abstract][Full Text] [Related]
36. The use of calcium antagonists in the therapy of hypertension in the elderly. Israili ZH Am J Ther; 2003; 10(6):383-95. PubMed ID: 14624275 [TBL] [Abstract][Full Text] [Related]
37. [Differential therapy with calcium antagonists]. Scholze JE Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111 [TBL] [Abstract][Full Text] [Related]
38. Use of calcium channel antagonists for the treatment of hypertension in the elderly. Steffen HM Drugs Aging; 2004; 21(9):565-81. PubMed ID: 15260512 [TBL] [Abstract][Full Text] [Related]
39. Nicardipine and treatment of cerebrovascular diseases with particular reference to hypertension-related disorders. Sabbatini M; Strocchi P; Amenta F Clin Exp Hypertens; 1995 Jul; 17(5):719-50. PubMed ID: 7655445 [TBL] [Abstract][Full Text] [Related]